Double-blind infusion device and method

• US 5,658,248 A
• Filed: 08/04/1995
• Issued: 08/19/1997
• Est. Priority Date: 08/04/1995
• Status: Expired due to Fees

• Current Assignee: LocalMed, LLC (Dental Intelligence, Inc.)
• Original Assignee: LocalMed, LLC (Dental Intelligence, Inc.)
• Inventors: Kaplan, Aaron V., Klein, Enrique J.
• Primary Examiner(s): Hafer, Robert A.
• Assistant Examiner(s): MENDEZ, MANUEL A
• Application Number:
  US08/511,567
• Time in Patent Office: 746 Days
• Field of Search: 604/49, 604/32, 604/246, 604/248, 604/30, 604/31, 604/33, 604/34
• US Class Current: 604/32
• CPC Class Codes: A61M 5/00 Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests vaccination appliances for veterinary use A61D1/025 ; tube connectors, tube couplings, valves or branch units specially adapted for medical use A61M39/00; containers specially adapted for medical or pharmaceutical purposes A61J1/00; combinations of vial and syringe for mixing or transferring their contents A61J1/20; holders for containers for collecting, storing or administering blood or medical fluids A61J1/16

Abstract

Type-A (operational) and type-B (non-operational) syringes (2A, 2B), used for double-blind clinical tests, are constructed so the type-B syringe mimics the operation of the type-A syringe while avoiding the delivery of anything into the patient. Each syringe includes an injector (4), a fluid connector (12) coupling the exit port (10) of the injector to a discharge port (14) to which a catheter or needle cannula is connected, a valve (18) positioned along the fluid connector, and a dumping reservoir (24) mounted to the valve. The type-A valve fluidly couples the exit port to the discharge port in both purging and infusion positions. The type-B valve couples the exit port to the discharge port in the purging position, but couples the exit port to the dumping reservoir in the infusion position. The infusate is directed through the catheter and into the patient when in the infusion position with the type-A valve but is directed into the dumping reservoir with the type-B valve.

Claims

1. A combination of A-type and B-type infusion devices, for use in double-blind clinical studies wherein an infusate is directed into a patient, comprising:

each of said type-A and type-B infusion devices comprising;

a substance injector having an exit port; and

a fluid connector having a discharge port defining a fluid path fluidly coupling the exit port with a discharge port;

said type-A device comprising a type-A valve assembly located along the fluid connector, said type-A valve assembly comprising a type-A valve having a first port coupled to the exit port by the fluid connector, a second port, a third port coupled to the discharged port by the fluid connector, and a moveable element positionable between purge and infusion positions, said moveable element forming first and second fluid passageways between the first and third ports when in purge and infusion positions, to fluidly couple the exit and discharge ports through the first and third ports of the valve;

said type-B device comprising a dumping reservoir and a type-B valve assembly located along the fluid connector, said type-B valve assembly comprising a type-B valve having a first port coupled to the exit port by the fluid connector, a second port coupled to the dumping reservoir, a third port coupled to the discharge port by the fluid connector, and a moveable element positionable between purge and infusion positions, wherein;

the moveable element forms a purging fluid passageway between the first and third ports when in the purge position so to fluidly couple the exit and discharge ports through the first and third ports, and wherein

the moveable element forms a dumping fluid passageway between the first and second ports when in the infusion position so to fluidly couple the exit port with the dumping reservoir through first and second ports, the first and third ports being fluidly isolated from one another when said B-type valve is in the infusion position;

said type-A valve assembly further comprising a dumping reservoir coupled to the second port but fluidly isolated from said exit port when said type-A valve is in the infusion and purge positions; and

said type-A and type-B infusion devices being externally effectively indistinguishable from each other.

2. The combination according to claim 1 wherein said substance injector comprises a barrel and a movable plunger movably mounted within the barrel.

3. The combination according to claim 1 wherein the fluid connector has a catheter fitting at the discharge port.

4. The combination according to claim 1 wherein the fluid connector has a hypodermic needle fitting at the discharge port.

5. The combination according to claim 1 wherein the type-A valve includes an intermediate position at which the exit port and the dumping reservoir are sealed.

6. The combination according to claim 1 wherein the dumping reservoir includes an anti-sloshing element to keep any infusate from sloshing around in the dumping reservoir.

7. The combination according to claim 6 wherein the anti-sloshing element is an absorbent anti-sloshing element.

8. The combination according to claim 1 wherein the dumping reservoir includes an air vent to provide relief for air being displaced by the fluid in the dumping reservoir.

9. The combination according to claim 1 further comprising means for restricting infusate flow into the dumping reservoir.

10. The combination according to claim 9 wherein the infusate flow restricting means is configured to mimic the infusate flow resistance created by infusate flowing from the type-A infusion device through a catheter.

11. The combination according to claim 1 wherein each said type-A and type-B device further comprises a pressure gauge fluidly coupled to the fluid path at a point between said exit port and said type-A and type-B valves, respectively.

12. The combination according to claim 1 wherein the dumping reservoir further comprises a reservoir body, an access member mounted to the reservoir body and a tamper-proof seal to indicate if the access member has been removed from the reservoir body.

13. The combination according to claim 1 wherein the type-A and type-B infusion devices are each marked with an encrypted serial number.

14. A method for directing an infusate into patients during a double-blind clinical study comprising the following step:

selecting type-A and type-B infusion devices, said type-A and type-B infusion devices comprising injectors containing fluid substances and dumping reservoirs, said type-A and said type-B infusion devices being externally effectively indistinguishable from one another;

placing said type-A and type-B infusion devices in infusion positions;

injecting said fluid substance from the type-A infusion device into a first patient;

using said type-B infusion device in the same manner as said type-A infusion device while said type-B infusion device;

automatically diverts said fluid substance from said type-B infusion device into said dumping reservoir of said type-B infusion device; and

mimics the operation of the type-A infusion device;

whereby there are no perceptible differences between the type-A and type-B infusion devices during use.

15. The method according to claim 14 further comprising the steps of:

placing said type-A and type-B infusion devices in purge positions; and

purging said type-A and type-B infusion devices of air.

16. The method according to claim 15 further comprising the step of connecting discharge port fittings of the type-A and type-B infusion devices to tubular delivery devices following said purging steps.

17. The method according to claim 16 wherein the connecting step includes the step of selecting tubular delivery devices from the group of catheters and needle cannulas.

18. The method according to claim 16 further comprising the step of purging air from the tubular delivery device following the connecting step.